A Leading Biopharmaceutical Company in China

About Us

As a leading biopharmaceutical company in China, Mabpharm Limited is focusing on the development and industrialization of new drugs and biosimilars for the treatment of cancer and autoimmune diseases. We are committed to bringing high-quality, affordable, and innovative biological drugs to the market through efficient research and development (R&D) systems, low-cost drug production capacity, and our extensive R&D experience to develop a diverse range of therapeutic products. Our drug pipeline currently consists of nine monoclonal antibody drugs and one probody drug.